Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck

JD Schultz, G Bran, C Anders, H Sadick… - Oncology …, 2010 - spandidos-publications.com
Squamous cell carcinoma of the head and neck (SCCHN) presents at a locally advanced
(LA) stage in many patients. Chemotherapy, which is one fundamental therapy mode for …

[HTML][HTML] A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of …

R Hitt, JJ Grau, A López-Pousa, A Berrocal… - Annals of …, 2014 - Elsevier
Background Concurrent chemoradiotherapy (CCRT) is the standard treatment for patients
with unresectable, nonmetastatic locoregionally advanced squamous-cell carcinoma of the …

[HTML][HTML] Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study

CY Hsieh, MY Lein, SN Yang, YC Wang, YJ Lin, CY Lin… - BMC cancer, 2020 - Springer
Background Phase 3 studies suggest that induction chemotherapy (ICT) of cisplatin and 5-
fluorouracil plus docetaxel (TPF) is effective but toxic for patients with squamous-cell …

Induction chemotherapy for head and neck squamous cell carcinomas (SCCHN)

MS Kies - Current treatment options in oncology, 2007 - Springer
Opinion statement Induction chemotherapy for squamous cell carcinoma of the head and
neck has long been known to be highly active with tumor responses observed in a high …

Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation

EC Ko, EM Genden, K Misiukiewicz… - Oncology …, 2012 - spandidos-publications.com
The use of induction chemotherapy prior to chemoradiation for locally advanced head and
neck squamous cell carcinoma (LA-HNSCC) remains controversial. We explored whether …

Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell …

L de Souza Viana, FC de Aguiar Silva… - Head & …, 2016 - Wiley Online Library
Background The purpose of this phase II trial was to evaluate the tolerability, safety, and
efficacy of a non–5‐fluorouracil (5‐FU)‐based induction chemotherapy followed by …

Reassessment of the role of induction chemotherapy for head and neck cancer

MK Gibson, AA Forastiere - The Lancet Oncology, 2006 - thelancet.com
Head and neck cancers are a complex group of diseases defined by variations in
histological features, anatomical location, and cause. Once the realm of surgeons and …

[HTML][HTML] Randomized controlled study comparing efficacy and toxicity of weekly vs. 3-weekly induction chemotherapy in locally advanced head and neck squamous …

D Tousif, V Sarathy, R Kumar, R Naik - Frontiers in Oncology, 2020 - frontiersin.org
Background: Head and Neck Cancer is a major public health problem in India, majority of
which are lifestyle related, male predominant requiring dedicated infrastructure and human …

New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011

AM Mumme, S Laban, R Knecht - European Archives of Oto-Rhino …, 2012 - Springer
Abstract Treatment options of patients with advanced head and neck cancer developed in
the last years. Surgical approaches with or without radiotherapy used to be the standard …

Toxicity of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil for advanced head and neck cancer.

S Billan, O Kaidar-Person, F Atrash… - The Israel Medical …, 2013 - europepmc.org
Background The role of induction chemotherapy in advanced squamous cell carcinoma of
the head and neck (SCCHN) is under constant debate. Surgery, radiotherapy …